Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
- PMID: 1552940
- DOI: 10.1038/356215a0
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Abstract
Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumorigenesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.
Similar articles
-
A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.Nat Genet. 1995 Mar;9(3):305-11. doi: 10.1038/ng0395-305. Nat Genet. 1995. PMID: 7773294
-
Gene replacement of the p53 gene with the lacZ gene in mouse embryonic stem cells and mice by using two steps of homologous recombination.Biochem Biophys Res Commun. 1994 Jul 29;202(2):830-7. doi: 10.1006/bbrc.1994.2005. Biochem Biophys Res Commun. 1994. PMID: 8048955
-
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.Nat Genet. 1993 Nov;5(3):225-9. doi: 10.1038/ng1193-225. Nat Genet. 1993. PMID: 8275085
-
Murine models of neoplasia: functional analysis of the tumour suppressor genes Rb-1 and p53.Cancer Metastasis Rev. 1995 Jun;14(2):125-48. doi: 10.1007/BF00665796. Cancer Metastasis Rev. 1995. PMID: 7554030 Review.
-
Transgenic mouse models for tumour-suppressor genes.J Intern Med. 1995 Sep;238(3):233-8. doi: 10.1111/j.1365-2796.1995.tb00928.x. J Intern Med. 1995. PMID: 7673852 Review.
Cited by
-
p53, a translational regulator: contribution to its tumour-suppressor activity.Oncogene. 2015 Oct 29;34(44):5513-23. doi: 10.1038/onc.2015.25. Epub 2015 Mar 2. Oncogene. 2015. PMID: 25728674 Review.
-
p53 mutations associated with aging-related rise in cancer incidence rates.Cell Cycle. 2013 Aug 1;12(15):2468-78. doi: 10.4161/cc.25494. Epub 2013 Jul 1. Cell Cycle. 2013. PMID: 23839036 Free PMC article.
-
Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain.Endocr Res. 2013 Aug;38(3):139-150. doi: 10.3109/07435800.2012.735735. Epub 2012 Oct 26. Endocr Res. 2013. PMID: 23102272 Free PMC article.
-
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions.Elife. 2016 Oct 19;5:e17929. doi: 10.7554/eLife.17929. Elife. 2016. PMID: 27759562 Free PMC article.
-
Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis.Biol Proced Online. 2012 Apr 17;14(1):6. doi: 10.1186/1480-9222-14-6. Biol Proced Online. 2012. PMID: 22510147 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous